- Home
- DSY vs IXHL Comparison
DSY vs IXHL Comparison
Compare DSY & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- IXHL
- Stock Information
- Founded
- DSY 2020
- IXHL 2001
- Country
- DSY China
- IXHL Australia
- Employees
- DSY N/A
- IXHL N/A
- Industry
- DSY
- IXHL
- Sector
- DSY
- IXHL
- Exchange
- DSY Nasdaq
- IXHL Nasdaq
- Market Cap
- DSY 57.6M
- IXHL 49.1M
- IPO Year
- DSY N/A
- IXHL N/A
- Fundamental
- Price
- DSY $0.87
- IXHL $0.44
- Analyst Decision
- DSY
- IXHL
- Analyst Count
- DSY 0
- IXHL 0
- Target Price
- DSY N/A
- IXHL N/A
- AVG Volume (30 Days)
- DSY 692.6K
- IXHL 36.4M
- Earning Date
- DSY 01-01-0001
- IXHL 11-13-2025
- Dividend Yield
- DSY N/A
- IXHL N/A
- EPS Growth
- DSY 120.37
- IXHL N/A
- EPS
- DSY 0.01
- IXHL N/A
- Revenue
- DSY $7,323,356.00
- IXHL $86,000.00
- Revenue This Year
- DSY N/A
- IXHL $1,188.37
- Revenue Next Year
- DSY N/A
- IXHL N/A
- P/E Ratio
- DSY $84.41
- IXHL N/A
- Revenue Growth
- DSY 16.37
- IXHL 616.67
- 52 Week Low
- DSY $0.87
- IXHL $0.08
- 52 Week High
- DSY $7.33
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- DSY 34.74
- IXHL 41.95
- Support Level
- DSY $1.20
- IXHL $0.43
- Resistance Level
- DSY $1.08
- IXHL $0.50
- Average True Range (ATR)
- DSY 0.10
- IXHL 0.07
- MACD
- DSY -0.04
- IXHL -0.01
- Stochastic Oscillator
- DSY 0.92
- IXHL 14.47
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.